Motohiro Hoshino
Motohiro Hoshino publishes mostly in Pharmacology, Radiology, Nuclear Medicine and Imaging and Molecular Biology, on topics such as Pharmacogenetics and Drug Metabolism, Drug Transport and Resistance Mechanisms and Genomics, phytochemicals, and oxidative stress.
- World rank
- #4,322,551 of 7,710,434 ranked researchers
- Rank in Japan
- #121,941 of 383,136
- Works
- 20
- Citations
- 173
- Citations per work
- 8.7
What does Motohiro Hoshino research?
Motohiro Hoshino's work is mostly in Medicine (35%), Pharmacology, Toxicology and Pharmaceutics (15%), Biochemistry, Genetics and Molecular Biology (10%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else839.6%
- Health Sciences735.4%
- Medicine735.4%
- Life Sciences525.0%
- 1Pharmacology15% of their works
- 2Radiology, Nuclear Medicine and Imaging10% of their works
- 3Molecular Biology10% of their works
- 4Ophthalmology10% of their works
- 5Oncology8% of their works
- 6Pediatrics, Perinatology and Child Health6% of their works
Research topics
- Pharmacogenetics and Drug Metabolism
- Drug Transport and Resistance Mechanisms
- Genomics, phytochemicals, and oxidative stress
- Glaucoma and retinal disorders
- Pharmacological Effects and Toxicity Studies
- Inflammatory mediators and NSAID effects
- Retinal Imaging and Analysis
- Bladder and Urothelial Cancer Treatments
Which keywords describe Motohiro Hoshino's research?
The keywords of their largest research topics: Cardiovascular Risk, Cytochrome P450, Glaucoma, Inflammation, Optic Nerve, Oxidative Stress, Pharmacogenetics and ATP-dependent Transporters.
- Retinal Ganglion Cells
- Prostaglandins
- Nrf2
- Intraocular Pressure
- Cyclooxygenase-2 Inhibitors
- Antiepileptic Drugs
- ATP-dependent Transporters
- Oxidative Stress
- Inflammation
- Cytochrome P450
- Cardiovascular Risk
- Glaucoma
- Optic Nerve
- Pharmacogenetics
- Multidrug Resistance
- Bladder Cancer
- Diabetic Retinopathy
- Keap1-Nrf2-ARE Pathway
- Prenatal Exposure
- Retinal Disease
- Urothelial Carcinoma
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Cardiovascular Risk62 topics
- Cytochrome P45061 topic
- Glaucoma62 topics
- Inflammation62 topics
- Optic Nerve62 topics
- Oxidative Stress62 topics
- Pharmacogenetics61 topic
- ATP-dependent Transporters41 topic
- Multidrug Resistance41 topic
- Antiepileptic Drugs31 topic
- Bladder Cancer31 topic
- Cyclooxygenase-2 Inhibitors31 topic
- Diabetic Retinopathy31 topic
- Intraocular Pressure31 topic
- Keap1-Nrf2-ARE Pathway31 topic
- Nrf231 topic
- Prenatal Exposure31 topic
- Prostaglandins31 topic
- Retinal Disease31 topic
- Retinal Ganglion Cells31 topic
- Urothelial Carcinoma31 topic
Where does Motohiro Hoshino work?
Motohiro Hoshino's main affiliation in the publication record is Hoshi University, Japan.
How many publications and citations does Motohiro Hoshino have?
OpenAlex counts 20 works and 173 citations for Motohiro Hoshino, an h-index of 9, ranking #4,322,551 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Motohiro Hoshino. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.